Core Laboratories Inc. (CLB)

NYSE: CLB · Precio en tiempo real · USD

12.52

-0.10 (-0.79%)

Al cierre: Aug 18, 2026, 3:59 PM

-0.79% (1D)

Precio de compra	n/a
Capitalización de mercado	574.47M
Ingresos (TTM)	519.18M
Beneficio neto (TTM)	24.35M
Beta	1.06
EPS (TTM)	0.52
Ratio PER (TTM)	24.08
Adelante PE	17.97
P/B (TTM)	2.11
P/S (TTM)	1.11
Earnings Date	Oct 28, 2026

Precio de venta	n/a
Volumen	443,829
Volumen medio (20D)	861,082
Abierto	12.63
Anterior Cerrar	12.62
Rango del día	12.25 - 12.62
Rango de 52 semanas	9.79 - 20.36
analista	n/a
Precio objetivo	n/a
Dividendos	$0.04 (0.32%)
Fecha ex dividendo	10 ago 2026

Acerca de CLB

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from ...

[Leer más]

Industria Oil & Gas Equipment & Services

Sector Energy

IPO Fecha Sep 21, 1995

Empleados 3,300

Bolsa de Valores NYSE

Símbolo bursátil CLB

Sitio web https://www.corelab.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Core Laboratories fueron 526.52M, un aumento de 0.51% en comparación con 523.85M del año anterior. Las ganancias fueron 29.67M, una disminución de -5.51%.

Estados financieros

Sorpresa de resultados

Core Laboratories ha publicado sus resultados trimestrales en Jul 29, 2026:

Ingresos de $124.61M falla las estimaciones por $0, con -4.26% Disminución interanual.

EPS de 0.11 supera las estimaciones en 0.02, con -42.11% Disminución interanual.

Próxima publicación de resultados

Está previsto que Core Laboratories Inc. publique sus resultados el Oct 28, 2026, después del cierre del mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

1 día hace · StockStory

3 Reasons CLB is Risky and 1 Stock to Buy Instead

Core Laboratories’s stock price has taken a beating over the past six months, shedding 33.5% of its value and falling to $12.46 per share. This might have investors contemplating their next move.

1 semana hace · Zacks

DTI or CLB: Which Is the Better Value Stock Right Now?

DTI vs. CLB: Which Stock Is the Better Value Option?

1 semana hace · StockStory

3 Stocks Under $50 with Warning Signs

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and invest...